Abstract
Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Current Topics in Medicinal Chemistry
Title:Allosteric Drugs and Seven Transmembrane Receptors
Volume: 13 Issue: 1
Author(s): Terry Kenakin
Affiliation:
Keywords: Allosteric modulation, allosteric antagonism, biased agonism, drug discovery, positive allosteric modulation efficacy, receptor theory
Abstract: Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.
Export Options
About this article
Cite this article as:
Kenakin Terry, Allosteric Drugs and Seven Transmembrane Receptors, Current Topics in Medicinal Chemistry 2013; 13 (1) . https://dx.doi.org/10.2174/1568026611313010003
DOI https://dx.doi.org/10.2174/1568026611313010003 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacotherapy of Dilated Cardiomyopathy
Current Pharmaceutical Design Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology Resveratrol in Cancer: Cellular and Mitochondrial Consequences of Proton Transport Inhibition
Current Pharmaceutical Design Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
Coronaviruses Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease
Current Cardiology Reviews Risk Factors for Heart Failure Progression and Outcomes
Current Cardiology Reviews Cell Death and Apoptosis in Ostearthritic Cartilage
Current Drug Targets Editorial (Thematic Issue: Pharmacological Considerations in Anesthesiology- From Organ Failure to Transplantation)
Current Clinical Pharmacology The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Current Molecular Medicine Recent Advances in Health Promoting Effect of Dietary Polyphenols
Current Nutrition & Food Science Sugammadex, a Promising Reversal Drug. A Review of Clinical Trials
Reviews on Recent Clinical Trials Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Physiological and Pharmacological Insights into the Role of Ionic Channels in Cardiac Pacemaker Activity
Cardiovascular & Hematological Disorders-Drug Targets Heart Failure
Current Hypertension Reviews The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
Current Diabetes Reviews Calpains: Potential Targets for Alternative Chemotherapeutic Intervention Against Human Pathogenic Trypanosomatids
Current Medicinal Chemistry Diagnosis and Management of Hypertensive Emergencies Complicating Pregnancy
Current Women`s Health Reviews Cardiotoxicity Assessment of Drugs Using Human iPS Cell-Derived Cardiomyocytes: Toward Proarrhythmic Risk and Cardio-Oncology
Current Pharmaceutical Biotechnology